The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
Induction of the Nrf2-driven Antioxidant Response Confers Neuroprotection during Mitochondrial Stress in Vivo
Open accessAbstract
NF-E2 related factor (Nrf2) controls a pleiotropic cellular defense, where multiple antioxidant/detoxification pathways are up-regulated in unison. Although small molecule inducers of Nrf2 activity have been reported to protect neurons in vitro, whether similar pathways can be accessed in vivo is not known. We have investigated whether in vivo toxicity of the mitochondrial complex II inhibitor 3-nitropropionic acid (3-NP) can be attenuated by constitutive and inducible Nrf2 activity. The absence of Nrf2 function in Nrf2(-/-) mice resulted in 3-NP hypersensitivity that became apparent with time and increasing dose, causing motor deficits and striatal lesions on a more rapid time scale than identically treated Nrf2(+/+) and Nrf2(+/-) controls. Striatal succinate dehydrogenase activity, the target of 3-NP, was inhibited to the same extent in all genotypes by a single acute dose of 3-NP, suggesting that brain concentrations of 3-NP were similar. Dietary supplementation with the Nrf2 inducer tert-butylhydroquinone attenuated 3-NP toxicity in Nrf2(+/-) mice, but not Nrf2(-/-), confirming the Nrf2-specific action of the inducer in vivo. Increased Nrf2 activity alone was sufficient to protect animals from 3-NP toxicity because intrastriatal adenovirus-mediated Nrf2 overexpression significantly reduced lesion size compared with green fluorescent protein overexpressing controls. In cultured astrocytes, 3-NP was found to increase Nrf2 activity leading to antioxidant response element-dependent gene expression providing a potential mechanism for the increased sensitivity of Nrf2(-/-) animals to 3-NP toxicity in vivo. We conclude that Nrf2 may underlie a feedback system limiting oxidative load during chronic metabolic stress.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Additionally, the Nrf2 activator tertbutylhydroquinone, has attenuated 3-NP toxicity in Nrf2+/+ mice, but not in Nrf2−/− mice185.”
From Mitochondrial Approaches for Neuroprotection (2008) · cites this paper as [185]
In the citing paper
“In the Nrf2 knockout (Nrf2−/−) mice, injection of the mitochondrial complex-II inhibitor 3-NP causes increased motor deficits and striatal lesions as compared to the Nrf2+/+ mice, and these toxic effects of 3-NP were protected by adenoviral mediated over expression of Nrf2185.”
From Mitochondrial Approaches for Neuroprotection (2008) · cites this paper as [185]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Rat Brain in Stereotaxic Coordinates
Paxinos, G., & Watson, C. (1983) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 28,585
The Mouse Brain in Stereotaxic Coordinates
Paxinos, G. (2001) · Cited by 12,859
Tietze, F. (1969) · Analytical Biochemistry · doi:10.1016/0003-2697(69)90064-5 · Cited by 6,077
Itoh, K., Chiba, T., Takahashi, S., Ishii, T., Igarashi, K., Katoh, Y., Oyake, T., Hayashi, N., Satoh, K., Hatayama, I., et al. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6943 · Cited by 3,999
Oxidative Stress, Glutamate, and Neurodegenerative Disorders
Coyle, J. T., & Puttfarcken, P. (1993) · Science · doi:10.1126/science.7901908 · Cited by 3,762
Itoh, K., Wakabayashi, N., Katoh, Y., Ishii, T., Igarashi, K., Engel, J. D., & Yamamoto, M. (1999) · Genes & Development · doi:10.1101/gad.13.1.76 · Cited by 3,634
The chemical diversity and distribution of glucosinolates and isothiocyanates among plants
Fahey, J. W., Zalcmann, A. T., & Talalay, P. (2001) · Phytochemistry · doi:10.1016/s0031-9422(00)00316-2 · Cited by 2,968
Dinkova-Kostova, A. T., Holtzclaw, W. D., Cole, R. N., Itoh, K., Wakabayashi, N., Katoh, Y., Yamamoto, M., & Talalay, P. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172398899 · Cited by 1,947
Ishii, T., Itoh, K., Takahashi, S., Sato, H., Yanagawa, T., Katoh, Y., Bannai, S., & Yamamoto, M. P. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.21.16023 · Cited by 1,473
Rushmore, T. H., Morton, M. R., & Pickett, C. B. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99004-6 · Cited by 1,464
Research works printed but not linked: 6
- Thimmulappa, 2002, Cancer Res., 62, 5196
- Kelly, 2000, Cancer Res., 60, 957
- McMahon, 2001, Cancer Res., 61, 3299
- O/WHO, 1975, FAO Nutr. Meet. Rep. Ser., 55A, 1
- O/WHO, 1997, Natl. Toxicol. Program Tech. Rep. Ser., 459, 1
- Kensler, 1993, Basic Life Sci., 61, 127
Cited by
Sorted by citations
Cell Survival Responses to Environmental Stresses Via the Keap1-Nrf2-ARE Pathway
Kensler, T. W., Wakabayashi, N., & Biswal, S. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.46.120604.141046 · Cited by 3,630
NRF2 and the Hallmarks of Cancer
Rojo de la Vega, M., Chapman, E., & Zhang, D. D. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.03.022 · Cited by 1,672
Hallmarks of Brain Aging: Adaptive and Pathological Modification by Metabolic States
Mattson, M. P., & Arumugam, T. V. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.05.011 · Cited by 1,242
Linker, R. A., Lee, D.-H., Ryan, S., van Dam, A. M., Conrad, R., Bista, P., Zeng, W., Hronowsky, X., Buko, A., Chollate, S., et al. (2011) · Brain · doi:10.1093/brain/awq386 · Cited by 1,155
Mechanistic Studies of the Nrf2-Keap1 Signaling Pathway
Zhang, D. D. (2006) · Drug Metabolism Reviews · doi:10.1080/03602530600971974 · Cited by 1,105
Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2
Wang, X.-J., Sun, Z., Villeneuve, N. F., Zhang, S., Zhao, F., Li, Y., Chen, W., Yi, X., Zheng, W., Wondrak, G. T., et al. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn095 · Cited by 839
Kobayashi, M., & Yamamoto, M. P. (2006) · Advances in Enzyme Regulation · doi:10.1016/j.advenzreg.2006.01.007 · Cited by 862
Calabrese, V., Cornelius, C., Dinkova‐Kostova, A. T., Calabrese, E. J., & Mattson, M. P. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.3074 · Cited by 817
Expression of Nrf2 in Neurodegenerative Diseases
Ramsey, C. P., Glass, C. A., Montgomery, M. B., Lindl, K. A., Ritson, G. P., Chia, L. A., Hamilton, R. L., Chu, C. T., & Jordan-Sciutto, K. L. (2007) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/nen.0b013e31802d6da9 · Cited by 760
Thomas, B., & Beal, M. F. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm159 · Cited by 748
Nrf2 regulates ROS production by mitochondria and NADPH oxidase
Kovac, S., Angelova, P. R., Holmström, K. M., Zhang, Y., Dinkova‐Kostova, A. T., & Abramov, A. Y. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2014.11.021 · Cited by 621
Johnson, J. A., Johnson, D. A., Kraft, A. D., Calkins, M. J., Jakel, R. J., Vargas, M. R., & Chen, P. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1427.036 · Cited by 595
Chen, P.-C., Vargas, M. R., Pani, A. K., Smeyne, R. J., Johnson, D. A., Kan, Y. W., & Johnson, J. A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813361106 · Cited by 579
Mechanisms of Neuroprotection by Quercetin: Counteracting Oxidative Stress and More
Costa, L. G., Garrick, J. M., Roqué, P. J., & Pellacani, C. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/2986796 · Cited by 550
Nrf2 signaling: An adaptive response pathway for protection against environmental toxic insults
Osburn, W. O., & Kensler, T. W. (2007) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2007.11.006 · Cited by 549
Discovery of the Negative Regulator of Nrf2, Keap1: A Historical Overview
Itoh, K., Mimura, J., & Yamamoto, M. P. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3222 · Cited by 521
Bae, S. H., Sung, S. H., Oh, S. Y., Lim, J. M., Lee, S. K., Park, Y. N., Lee, H. E., Kang, D., & Rhee, S. G. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2012.12.002 · Cited by 492
Vargas, M. R., Johnson, D. A., Sirkis, D. W., Messing, A., & Johnson, J. A. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4099-08.2008 · Cited by 479
Two-site substrate recognition model for the Keap1-Nrf2 system: A hinge and latch mechanism
Tong, K. I., Kobayashi, A., Katsuoka, F., & Yamamoto, M. (2006) · Biological Chemistry · doi:10.1515/bc.2006.164 · Cited by 473
The Nrf2/ARE Pathway as a Potential Therapeutic Target in Neurodegenerative Disease
Calkins, M. J., Johnson, D. A., Townsend, J. A., Vargas, M. R., Dowell, J. A., Williamson, T. P., Kraft, A. D., Lee, J., Li, J., & Johnson, J. A. (2008) · Antioxidants and Redox Signaling · doi:10.1089/ars.2008.2242 · Cited by 441
de Vries, H. E., Witte, M. E., Hondius, D., Rozemüller, A. J. M., Drukarch, B., Hoozemans, J. J. M., & van Horssen, J. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.09.001 · Cited by 436
Mitochondrial Diseases of the Brain
Chaturvedi, R. K., & Beal, M. F. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.03.018 · Cited by 426
Shih, A. Y., Li, P., & Murphy, T. H. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4014-05.2005 · Cited by 413
Self-citationThe multifaceted role of Nrf2 in mitochondrial function
Holmström, K. M., Kostov, R. V., & Dinkova-Kostova, A. T. (2016) · Current Opinion in Toxicology · doi:10.1016/j.cotox.2016.10.002 · Cited by 368
Natural product-derived pharmacological modulators of Nrf2/ARE pathway for chronic diseases
Kumar, H., Kim, I., More, S. V., Kim, B.-W., & Choi, D. (2013) · Natural Product Reports · doi:10.1039/c3np70065h · Cited by 338
The Nrf2–Keap1 defence pathway: Role in protection against drug-induced toxicity
Copple, I. M., Goldring, C. E., Kitteringham, N. R., & Park, B. K. (2007) · Toxicology · doi:10.1016/j.tox.2007.10.029 · Cited by 336
Nrf2—a therapeutic target for the treatment of neurodegenerative diseases
Johnson, D. A., & Johnson, J. A. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.07.147 · Cited by 333
Radical changes in multiple sclerosis pathogenesis
van Horssen, J., Witte, M. E., Schreibelt, G., & de Vries, H. E. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.06.011 · Cited by 325
Shih, A. Y., Erb, H., Sun, X., Toda, S., Kalivas, P. W., & Murphy, T. H. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.3178-06.2006 · Cited by 315
Self-citationPGAM5 tethers a ternary complex containing Keap1 and Nrf2 to mitochondria
Lo, S.-C., & Hannink, M. (2008) · Experimental Cell Research · doi:10.1016/j.yexcr.2008.02.014 · Cited by 300
Oxidative Damage in Huntington's Disease Pathogenesis
Browne, S. E., & Beal, M. F. (2006) · Antioxidants and Redox Signaling · doi:10.1089/ars.2006.8.2061 · Cited by 313
NRF2 as a Therapeutic Target in Neurodegenerative Diseases
Brandes, M. S., & Gray, N. E. (2020) · ASN Neuro · doi:10.1177/1759091419899782 · Cited by 297
Mitochondrial Approaches for Neuroprotection
Chaturvedi, R. K., & Beal, M. F. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1427.027 · Cited by 294
The Nrf2–ARE cytoprotective pathway in astrocytes
Vargas, M. R., & Johnson, J. A. (2009) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399409001094 · Cited by 295
Mechanistic insights and perspectives involved in neuroprotective action of quercetin
Grewal, A. K., Singh, T. G., Sharma, D., Sharma, V., Singh, M., Rahman, M. H., Najda, A., Walasek-Janusz, M., Kamel, M. S., Albadrani, G. M., et al. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111729 · Cited by 295
Antioxidants: Positive or Negative Actors?
Salehi, B., Martorell, M., Arbiser, J. L., Sureda, A., Martins, N. A., Maurya, P. K., Sharifi‐Rad, M., Kumar, P., & Sharifi‐Rad, J. (2018) · Biomolecules · doi:10.3390/biom8040124 · Cited by 266
Nuclear factor erythroid 2-related factor 2 protects against beta amyloid
Kanninen, K. M., Malm, T., Jyrkkänen, H.-K., Goldsteins, G., Keksa-Goldsteine, V., Tanila, H., Yamamoto, M. P., Ylä‐Herttuala, S., Levonen, A., & Koıstınaho, J. (2008) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2008.07.010 · Cited by 259
Antioxidant and bioenergetic coupling between neurons and astrocytes
Fernandez-Fernandez, S., Almeida, A., & Bolaños, J. P. (2012) · Biochemical Journal · doi:10.1042/bj20111943 · Cited by 247
The Nrf2-ARE Pathway: A Valuable Therapeutic Target for the Treatment of Neurodegenerative Diseases
Gururaj Joshi, A., & Johnson, J. A. (2012) · Recent Patents on CNS Drug Discovery · doi:10.2174/157488912803252023 · Cited by 246
Peroxisome proliferator-activated receptor γ (PPARγ): A master gatekeeper in CNS injury and repair
Cai, W., Yang, T., Liu, H., Han, L., Zhang, K., Hu, X., Zhang, X., Yin, K., Gao, Y., Bennett, M. V. L., et al. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.10.002 · Cited by 240
Oxidative Stress and Huntington’s Disease: The Good, the Bad, and the Ugly
Kumar, A., & Ratan, R. R. (2016) · Journal of Huntington s Disease · doi:10.3233/jhd-160205 · Cited by 236
Transcription Factor Nrf2 Protects the Brain From Damage Produced by Intracerebral Hemorrhage
Zhao, X., Sun, G., Zhang, J., Strong, R., Dash, P. K., Kan, Y. W., Grotta, J. C., & Aronowski, J. A. (2007) · Stroke · doi:10.1161/strokeaha.107.486506 · Cited by 227
Nrf2/ARE Signaling Pathway: Key Mediator in Oxidative Stress and Potential Therapeutic Target in ALS
Petri, S., Körner, S., & Kiaei, M. (2012) · Neurology Research International · doi:10.1155/2012/878030 · Cited by 227
Osburn, W. O., Wakabayashi, N., Misra, V., Nilles, T. L., Biswal, S. S., Trush, M. A., & Kensler, T. W. (2006) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2006.08.005 · Cited by 225
Túnez, I., Tasset, I., de la Cruz, V. P., & Santamarı́a, A. (2010) · Molecules · doi:10.3390/molecules15020878 · Cited by 225
Acute oxidative stress and systemic Nrf2 activation by the ketogenic diet
Milder, J. B., Liang, L., & Patel, M. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.05.030 · Cited by 214
Hannan, M. A., Dash, R., Sohag, A. A. M., Haque, M. N., & Moon, I. S. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.00116 · Cited by 215
Hwang, Y. P., & Jeong, H. G. (2009) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2009.09.009 · Cited by 187
Li, H., Song, F., Duan, L.-R., Sheng, J., Xie, Y., Yang, Q., Chen, Y., Dong, Q., Zhang, B., & Wang, S. (2016) · Scientific Reports · doi:10.1038/srep23693 · Cited by 186
Cheng, X., Siow, R. C. M., & Mann, G. E. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3283 · Cited by 182
Modulation of oxidative stress and mitochondrial function by the ketogenic diet
Milder, J. B., & Patel, M. (2011) · Epilepsy Research · doi:10.1016/j.eplepsyres.2011.09.021 · Cited by 181
Sarlette, A., Krampfl, K., Grothe, C., Neuhoff, N. V., Dengler, R., & Petri, S. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31818b4906 · Cited by 179
Gopinath, K., & Sudhandiran, G. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.07.060 · Cited by 174
Narayanan, S., Kalayarasan, S., & Sudhandiran, G. (2008) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2008.12.010 · Cited by 175
Yang, L., Calingasan, N. Y., Thomas, B., Chaturvedi, R. K., Kiaei, M., Wille, E. J., Liby, K. T., Williams, C. R., Royce, D. B., Risingsong, R., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005757 · Cited by 173
Schreibelt, G., van Horssen, J., van Rossum, S., Dijkstra, C. D., Drukarch, B., & de Vries, H. E. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.07.005 · Cited by 176
Mahmoud, A. M., Germoush, M. O., Alotaibi, M., & Hussein, O. E. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.12.047 · Cited by 169
Are Astrocytes the Predominant Cell Type for Activation of Nrf2 in Aging and Neurodegeneration?
Liddell, J. R. (2017) · Antioxidants · doi:10.3390/antiox6030065 · Cited by 172
Regulation of haeme oxygenase‐1 for treatment of neuroinflammation and brain disorders
Syapin, P. J. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.342 · Cited by 164
Lee, D.-H., Gold, R., & Linker, R. A. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms130911783 · Cited by 163
The endocannabinoid system in normal and pathological brain ageing
Bilkei‐Gorzó, A. (2012) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2011.0388 · Cited by 161
Efficacy of Fumaric Acid Esters in the R6/2 and YAC128 Models of Huntington's Disease
Ellrichmann, G., Petrasch‐Parwez, E., Lee, D.-H., Reick, C., Arning, L., Carsten Saft, C., Gold, R., & Linker, R. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016172 · Cited by 155
Redox regulation of neuronal survival mediated by electrophilic compounds
Satoh, T., & Lipton, S. A. (2006) · Trends in Neurosciences · doi:10.1016/j.tins.2006.11.004 · Cited by 156
Mahmoud, A. M., Hussein, O. E., Hozayen, W. G., & El-Twab, S. M. A. (2017) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2017.04.009 · Cited by 154
Mahmoud, A. M., & Dera, H. S. A. (2015) · Genes & Nutrition · doi:10.1007/s12263-015-0491-1 · Cited by 154
Chatoo, W., Abdouh, M., David, J., Champagne, M.-P., Ferreira, J., Rodier, F., & Bernier, G. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.5303-08.2009 · Cited by 150
Mitochondria targeted therapeutic approaches in Parkinson's and Huntington's diseases
Chaturvedi, R. K., & Beal, M. F. (2012) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2012.11.011 · Cited by 139
Critical role of Nrf2 in oxidative stress‐induced retinal ganglion cell death
Himori, N., Yamamoto, K. T., Maruyama, K., Ryu, M., Taguchi, K., Yamamoto, M. P., & Nakazawa, T. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12325 · Cited by 132
Inman, D. M., Lambert, W. S., Calkins, D. J., & Horner, P. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065389 · Cited by 135
NRF2, cancer and calorie restriction
Martín‐Montalvo, A., Villalba, J. M., Navas, P., & de Cabo, R. (2010) · Oncogene · doi:10.1038/onc.2010.492 · Cited by 129
Mahmoud, A. M., Mohammed, H. M., Khadrawy, S. M., & Galaly, S. R. (2017) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2017.09.015 · Cited by 129
Wang, L., & Gallagher, E. P. (2012) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2012.11.010 · Cited by 130
Cavaleri, F., & Bashar, E. (2018) · Journal of Nutrition and Metabolism · doi:10.1155/2018/7195760 · Cited by 126
Zhao, X., Gonzales, N. R., & Aronowski, J. A. (2014) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12350 · Cited by 122
Succinate: An initiator in tumorigenesis and progression
Zhao, T., Mu, X., & You, Q. (2017) · Oncotarget · doi:10.18632/oncotarget.17734 · Cited by 118
Neuroinflammation in Huntington’s Disease: A Starring Role for Astrocyte and Microglia
Saba, J., Couselo, F. L., Bruno, J., Carniglia, L., Durand, D., Lasaga, M., & Caruso, C. (2022) · Current Neuropharmacology · doi:10.2174/1570159x19666211201094608 · Cited by 117
Vacuolar Leukoencephalopathy with Widespread Astrogliosis in Mice Lacking Transcription Factor Nrf2
Hubbs, A. F., Benkovic, S. A., Miller, D. B., O'Callaghan, J. P., Battelli, L. A., Schwegler‐Berry, D., & Ma, Q. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.060898 · Cited by 116
Keap1‐Nrf2 activation in the presence and absence of DJ‐1
Gan, L., Johnson, D. A., & Johnson, J. A. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07138.x · Cited by 113
Counteracting role of nuclear factor erythroid 2-related factor 2 pathway in Alzheimer's disease
Sharma, V., Kaur, A., & Singh, T. G. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110373 · Cited by 116
Baitharu, I., Jain, V., Deep, S. N., Shroff, S., Sahu, J. K., Naik, P. K., & Ilavazhagan, G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105311 · Cited by 111
Kraft, A. D., Lee, J., Johnson, D. A., Kan, Y. W., & Johnson, J. A. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04019.x · Cited by 107
Age-associated oxidative damage to the p62 promoter: implications for Alzheimer disease
Du, Y., Wooten, M. C., Gearing, M., & Wooten, M. W. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.11.003 · Cited by 108
Nrf2 promotes neuronal cell differentiation
Zhao, F. L., Wu, T., Lau, A., Jiang, T., Huang, Z., Wang, X.-J., Chen, W., Wong, P. K., & Zhang, D. D. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.06.029 · Cited by 103
Kandeil, M. A., Mohammed, E. T., Hashem, K. S., Aleya, L., & Abdel‐Daim, M. M. (2019) · Environmental Science and Pollution Research · doi:10.1007/s11356-019-05514-2 · Cited by 106
Ferroptosis regulation through Nrf2 and implications for neurodegenerative diseases
Xiang, Y., Song, X., & Long, D. (2024) · Archives of Toxicology · doi:10.1007/s00204-023-03660-8 · Cited by 116
Activation of Nrf2-ARE signal pathway protects the brain from damage induced by epileptic seizure
Wang, W., Wu, Y., Zhang, G., Fang, H.-B., Wang, H., Zang, H., Xie, T., & Wang, W. (2013) · Brain Research · doi:10.1016/j.brainres.2013.12.004 · Cited by 100
Nakaso, K., Nakamura, C., Sato, H., Imamura, K., Takeshima, T., & Nakashima, K. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.11.095 · Cited by 99
Neuronal activity regulates astrocytic Nrf2 signaling
Habas, A., Hahn, J., Wang, X., & Margeta, M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1208764110 · Cited by 100
Wang, H., Xu, Y., & Zhu, C. (2011) · Neurotoxicity Research · doi:10.1007/s12640-011-9292-5 · Cited by 95
Siebert, A. A., Desai, V., Chandrasekaran, K., Fiskum, G. M., & Jafri, M. S. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.21975 · Cited by 95
Copple, I. M., Goldring, C. E., Kitteringham, N. R., & Park, B. K. (2009) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-00663-0_9 · Cited by 98
Granado, N., Lastres‐Becker, I., Ares‐Santos, S., Oliva, I., Martín, E. D., Cuadrado, A., & Moratalla, R. (2011) · Glia · doi:10.1002/glia.21229 · Cited by 93
Feng, X., Peng, Y., Liu, M., & Cui, L. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.10.009 · Cited by 91
Screening of Natural Compounds as Activators of the Keap1-Nrf2 Pathway
Wu, K. C., McDonald, P. R., Liu, J., & Klaassen, C. D. (2013) · Planta Medica · doi:10.1055/s-0033-1351097 · Cited by 90
Sun, X., Shih, A. Y., Johannssen, H. C., Erb, H., Li, P., & Murphy, T. H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601567200 · Cited by 93
Self-citationThe Multifaceted Roles of NRF2 in Cancer: Friend or Foe?
Glorieux, C., Enriquez-Lara, C., González, C. D., Aguirre-Martínez, G. V., & Calderón, P. B. (2024) · Antioxidants · doi:10.3390/antiox13010070 · Cited by 97
Neuronal Responses to Physiological Stress
Kagias, K., Nehammer, C., & Pocock, R. (2012) · Frontiers in Genetics · doi:10.3389/fgene.2012.00222 · Cited by 94
Bahia, P. K., Rattray, M., & Williams, R. J. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05542.x · Cited by 86
Zhang, Y., Ahmad, K. A., Khan, F. U., Yan, S., Ihsan, A. U., & Ding, Q. (2019) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2019.03.027 · Cited by 84
Lim, J. L., Wilhelmus, M. M. M., de Vries, H. E., Drukarch, B., Hoozemans, J. J. M., & van Horssen, J. (2014) · Archives of Toxicology · doi:10.1007/s00204-014-1338-z · Cited by 84
Metadata
- Authors
- Shih, A. Y., Imbeault, S., Barakauskas, V., Erb, H., Jiang, L., Li, P., & Murphy, T. H.
- Affiliations
- University of British Columbia (CA)
- Corresponding author
- Murphy, Timothy H.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2005-06
- Volume
- 280
- Issue
- 24
- Pages
- 22925-22936
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2028243150
- Cited by
- 273
- References
- 80
- Citations by year
- 2026: 7 · 2025: 4 · 2024: 9 · 2023: 3 · 2022: 4 · 2021: 10 · 2020: 8 · 2019: 7 · 2018: 17 · 2017: 11 · 2016: 16 · 2015: 13 · 2014: 12 · 2013: 17 · 2012: 26
- FWCI
- 5.61
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Heart and Stroke Foundation of Canada
- University of Ottawa
- Rick Hansen Institute
- Canadian Stroke Network
- Michael Smith Health Research BC
- University of British Columbia
- Canadian Institutes of Health Research
- Natural Sciences and Engineering Research Council of Canada
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics, phytochemicals, and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Keywords
- Nrf2, antioxidant response element, neuroprotection, mitochondrial complex II inhibition, 3-nitropropionic acid, succinate dehydrogenase, striatal lesions, motor impairment, tert-butylhydroquinone, Nrf2 inducers, oxidative stress, astrocytes, adenoviral overexpression, Nrf2 knockout mice, metabolic stress
- MeSH terms
- Adenoviridae, Alkaline Phosphatase, Animals, Antioxidants, Astrocytes, Behavior, Animal, Brain, DNA-Binding Proteins, Dose-Response Relationship, Drug, Female, Genotype, Glutathione, Hydroquinones, Immunohistochemistry, Male, Mice, Transgenic, Mitochondria, Neuroglia, Neurons, Nitro Compounds, Placenta, Plasmids, Propionates, Succinate Dehydrogenase, Time Factors, Transfection, Blotting, Western, Trans-Activators, Up-Regulation, Rats, Wistar, DNA Primers, Oxidative Stress, COS Cells, Dietary Supplements, Reverse Transcriptase Polymerase Chain Reaction, Green Fluorescent Proteins, NF-E2-Related Factor 2, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review